Scholarlink

Background <p>Dosing of antibiotics proves to be both crucial and especially challenging in critically ill patients due to extracorporeal therapies. In this exploratory study, we compared the influence of the albumin based ADVanced Organ Support (ADVOS) system to conventional continuous venovenous hemodialysis (CVVHD) on linezolid serum concentrations.</p> Methods <p>A total of 14 critically ill patients (8 ADVOS, 6 CVVHD) receiving linezolid 600&#xa0;mg twice daily were analyzed, comprising 22 measurement cycles. Machine clearance was calculated by pre- and post-filter concentrations; total and patient clearance were estimated by area under the curve (AUC) calculations. Linezolid pharmacokinetics were evaluated by C<sub>min</sub> and estimated AUC<sub>24</sub>, considering target ranges. All parameters were compared between dialysis types.</p> Results <p>Machine clearance was significantly higher in ADVOS than in CVVHD (median 3.4 vs. 1.6&#xa0;L/h, <i>p</i> &lt; 0.001), accounting for a higher share of total clearance (38.1% vs. 18.2%). Total clearance (9.3 vs. 10.4&#xa0;L/h) and patient clearance (6.7 vs. 8.4&#xa0;L/h) did not differ significantly, nor did AUC24 (250.9 vs. 221.2&#xa0;mg·h/L) or Cmin (4.6 vs. 4.0&#xa0;mg/L). A substantial proportion of subtherapeutic serum concentrations was observed in both groups (45.5% by AUC24 and 31.8% by Cmin).</p> Conclusion <p>This in-vivo study provides real-life data of linezolid levels in ICU-patients treated with conventional CVVHD and ADVOS. The high occurrence of subtherapeutic serum concentrations and a significant difference in dialysis capacities depending on dialysis type indicate the necessity of a tailored therapeutic drug monitoring approach in this vulnerable population.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Serum concentrations and pharmacokinetics of linezolid in critically ill patients dialyzed by ADVanced Organ Support compared to conventional continuous renal replacement therapy

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月10日

查看全文
  • Julian Triebelhorn,
  • Johanna Erber,
  • Heike Schneider,
  • Jochen Schneider,
  • Laura Wagner,
  • Yizhu Li,
  • Eva Ortner,
  • Roland M. Schmid,
  • Ulrich Mayr,
  • Tobias Lahmer,
  • Miriam Dibos

摘要

Background

Dosing of antibiotics proves to be both crucial and especially challenging in critically ill patients due to extracorporeal therapies. In this exploratory study, we compared the influence of the albumin based ADVanced Organ Support (ADVOS) system to conventional continuous venovenous hemodialysis (CVVHD) on linezolid serum concentrations.

Methods

A total of 14 critically ill patients (8 ADVOS, 6 CVVHD) receiving linezolid 600 mg twice daily were analyzed, comprising 22 measurement cycles. Machine clearance was calculated by pre- and post-filter concentrations; total and patient clearance were estimated by area under the curve (AUC) calculations. Linezolid pharmacokinetics were evaluated by Cmin and estimated AUC24, considering target ranges. All parameters were compared between dialysis types.

Results

Machine clearance was significantly higher in ADVOS than in CVVHD (median 3.4 vs. 1.6 L/h, p < 0.001), accounting for a higher share of total clearance (38.1% vs. 18.2%). Total clearance (9.3 vs. 10.4 L/h) and patient clearance (6.7 vs. 8.4 L/h) did not differ significantly, nor did AUC24 (250.9 vs. 221.2 mg·h/L) or Cmin (4.6 vs. 4.0 mg/L). A substantial proportion of subtherapeutic serum concentrations was observed in both groups (45.5% by AUC24 and 31.8% by Cmin).

Conclusion

This in-vivo study provides real-life data of linezolid levels in ICU-patients treated with conventional CVVHD and ADVOS. The high occurrence of subtherapeutic serum concentrations and a significant difference in dialysis capacities depending on dialysis type indicate the necessity of a tailored therapeutic drug monitoring approach in this vulnerable population.